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HORMESIS AND THE SALK POLIO VACCINE
Edward J. Calabrese, Ph.D.  University of Massachusetts
 The production of the Salk vaccine polio virus by monkey kidney cells was generated
using the synthetic tissue culture medium, Mixture 199. In this paper’s retrospective
assessment of this process, it was discovered that Mixture 199 was modified by the addition
of ethanol to optimize animal cell survival based on experimentation that revealed a
hormetic-like biphasic response relationship. This hormesis-based optimization proce-
dure was then applied to all uses of Mixture 199 and modifications of it, including its appli-
cation to the Salk polio vaccine during preliminary testing and in its subsequent major
societal treatment programs.
Key Words: hormesis, biphasic, hormetic, polio, ethanol, Salk vaccine
INTRODUCTION
Jonas Salk is credited with the development of the first effective polio
vaccine. After years of research, he developed the vaccine in 1952, with
the results of subsequent pilot testing in children and adults published in
1953 (Salk, 1953). The vaccine was later successfully piloted again in chil-
dren in the Pittsburgh, Pennsylvania area in 1954. Based on these find-
ings, Salk’s vaccine was then tested in a very large field trial directed by
Thomas Francis at the University of Michigan. The “Francis Field Trial”
was the largest medical experiment in history, a test that would include
nearly two million children from 44 states. The study involved about
440,000 children receiving one or more vaccine injections, 210,000 chil-
dren given a placebo while 1.2 million children received no vaccine, serv-
ing as an unexposed control group (Lambert and Markel, 2000). On
April 12, 1955 the successful results of the field trial were announced
(www.sph.umich.edu/about/polioannouncement.html). Soon after-
wards the vaccine became licensed and vaccinations to prevent polio were
introduced throughout the US.
In order to satisfy the goal of a mass vaccination program involving
millions of children within a tight schedule it was necessary to develop
the means to standardize and optimize the production of the virus from
monkey kidney cells. The object of the present paper is to provide evi-
dence that the tissue culture method used for the production of the Salk
vaccine in preliminary testing and societal implementation was optimized
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by Parker et al. (1950) using what has proved to be the concept of horme-
sis. This finding was unexpectedly discovered during an assessment of the
occurrence of hormesis in the wound healing process. An aspect of the
history of wound healing involves how tissue culture has been used to
screen agents for their capacity to enhance the healing process. During
this paper’s assessment the research of Raymond C. Parker was followed
and it led to the unearthing of how he used the hormesis concept to opti-
mize the capacity of the synthetic tissue culture medium, Mixture 199, to
support cell proliferation and survival.
HORMESIS AND MIXTURE 199
Hormesis is a dose response phenomenon characterized by a low
stimulation and a high dose inhibition (Calabrese, 2008a). The term
hormesis was first used by Southam and Ehrlich (1943) to describe how
extracts from the red cedar tree affected the metabolism of a number of
fungal species. The actual concept of a biphasic dose-response preceded
the term hormesis by nearly six decades, having been first reported by
Schulz (1887, 1888) based on experiments assessing the effects of multi-
ple disinfectants on the metabolism of yeasts (Calabrese, 2005a;
Calabrese, 2009). Hormetic dose responses are now considered to be
broadly generalized, being independent of biological model, endpoint
measured and the class of chemical inducing agent (Calabrese and Blain,
2005, 2011; Calabrese, 2005b.; Calabrese 2008a; Calabrese 2008b;
Calabrese, 2010). Hormetic dose responses also display specific quantita-
tive features of the dose response, with the stimulatory response being
modest, typically 30-60% greater than the controls, while the stimulatory
range is usually in the 10-20 fold range, starting immediately below the
estimated pharmacological or toxicological threshold (Calabrese and
Baldwin, 1997, 2001; Calabrese and Blain, 2005; 2009).
Mixture 199 was developed as part of a cancer cell nutrition project
under the direction of Parker (Morgan et al., 1950; Morton et al., 1950;
Rhodes, 1956). Mixture 199 was a synthetic tissue culture medium with-
out animal serum, offering the advantage of avoiding potential allergenic
responses which would be very problematic in a widely distributed vac-
cine. Salk became aware of Mixture 199 and saw its potential use as an
important component in the overall polio vaccine project, using it in the
1952 pilot polio study (Salk, 1953), and in a subsequent large scale test
(Rhodes, 1956) and the major societal polio vaccine program.
It was within the context of maximizing the production of the virus
that the hormesis concept entered the discussion. During attempts to
optimize the functioning of Mixture 199, it was necessary to add a mem-
ber of the Tween series of surface-active agents. Tweens serve both as a
source of water-soluble fatty acids and as a way to dissolve and disperse fat-
soluble compounds such as vitamins A and D and cholesterol throughout
E. J. Calabrese
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the medium. However, before the vitamins and cholesterol could be
added to Mixture 199 solution, it was necessary to make an alcoholic
(ethanol) stock solution of these agents and to dilute this with Tween.
This product yielded a clear solution when highly diluted in the aqueous
medium. Follow-up experiments indicated that the survival of the cul-
tured animal cells (i.e., chicken mesenchyme embryo cells), was reduced
at certain concentrations of Tween and alcohol (Morton et al., 1950;
Morgan et al., 1950). However, if the ethanol concentration was reduced
to 0.001% the tissue culture survival returned to normal while the Tween
could still be used at its optimal level. Since an adequate synthetic mix-
ture for growing animal cells was believed to require other alcohol-solu-
ble agents, Parker et al. (1950) decided it was important to establish the
concentrations of ethanol that could be used within Mixture 199 with
0.002% Tween. The Parker study assessed the effects of ethanol upon the
survival and outgrowth of fibroblast-like spindle cells from 11-day old
chick embryos grown in the synthetic Mixture 199 with a broad range of
ethanol concentrations using either roller tube or flask cultures (Parker
et al., 1950). In both cases there was a hormetic biphasic concentration-
response relationship. The optimal response for these experiments
(based on Table 2 and Figures 5-8 of Parker et al., 1950) was in the 0.02-
0.50% range, increasing cell survival and cell migration by about 30-50%
(Figure 1).
Hormesis and the Salk Polio Vaccine
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FIGURE 1. Effects of Ethanol on the Survival Time of Roller-Tube Culture of Chick Embryo
Mesenchyne Cells Maintained in Synthetic Mixture 199 (Source: Parker et al., 1950). 
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Parker et al. (1950) concluded that ethanol would not adversely affect
cultured animal cells when kept < 1%. These findings were seen as impor-
tant since they established the level of alcohol that could be used safely in
tissue culture studies. The findings also provided the basis for changing
the concentration of ethanol in Mixture 199 from 0.001% to 0.2%, based
on the peak of the stimulatory (i.e. hormetic) response. Mixture 199
would become the culture medium used to grow the monkey kidney cells
for the Salk Polio trials and vaccination program. Within a few years,
Mixture 199 would become modified and be called H597. However, the
concentration of ethanol was retained in the modified H597 (Healy et al.,
1971). Although optimizing of Mixture 199 to enhance cell survival was
expected to play a key role in the tissue culture performance for the pro-
duction of the polio virus, there is no evidence to indicate how increas-
ing the ethanol concentration to 0.2% affected the survival of the mon-
key kidney cells and their capacity to produce polio virus. Decades after
its initial role in the Salk Polio Vaccine project, it has been determined
that the hormesis concept was practically implemented into the massive
manufacturing process that resulted in the production of sufficient vac-
cine to immunize millions of children against the profoundly harmful
effects of polio. What is not explicitly known is whether the increase in
ethanol, which had a significant effect on the survival of chicken embryo
cells, also had a similar enhancing effect on the monkey kidney cells
employed for the polio virus production.
REFERENCES
Calabrese, E.J. 2010. Hormesis is central to toxicology, pharmacology and risk assessment. Hum.
Exper. Toxicol., 29:249-261.
Calabrese, E.J. 2009. Getting the dose-response wrong: Why hormesis became marginalized and the
threshold model accepted. Arch. Toxicol., 83:227-247.
Calabrese, E.J. 2008a. Hormesis: Why it is important to toxicology and toxicologists. Environ. Toxicol.
Chem., 27:1451-1474.
Calabrese, E.J. 2008b. Hormesis and medicine. Brit. J. Clin. Pharmacol., 66:594-617.
Calabrese, E.J. 2005a. Historical blunders: How toxicology got the dose-response relationship half
right. Cell. Mol. Biol., 51:643-654.
Calabrese, E.J. 2005b. Paradigm lost, paradigm found: The re-emergence of hormesis as a funda-
mental dose response model in the toxicological sciences. Env. Poll., 138:379-411.
Calabrese, E.J., and Baldwin, L.A. 2001. Hormesis: U-shaped dose response and their centrality in tox-
icology. Trends Pharmacol. Sci. 22(6):285-291.
Calabrese, E.J., and Baldwin, L.A. 1997. The dose determines the stimulation (and poison):
Development of a chemical hormesis database. Int. J. Toxicol., 16:545-559.
Calabrese, E.J., and Blain, R.B. 2011. The hormesis database: the occurrence of hormetic dose
responses in the toxicological literature. Reg. Toxicol. Pharmacol., 61:73-81.
Calabrese, E.J., and Blain, R.B. 2009. Hormesis and plant biology. Environ. Poll., 157:42-48.
Calabrese, E.J., and Blain, R. 2005. The occurrence of hormetic dose responses in the toxicological
literature, the hormesis database: an overview. Toxicol. Appl. Pharmacol, 202:289-301.
Healy, G.M., Teleki, S., Seefried, A.V., Walton, M.J., and Macmorine, H.G. 1971. Improved chemical-
ly defined basal medium (CMRL-1969) for primary monkey kidney and human diploid cells.
Appl. Microbiol., 21:1-5.
Lambert, S.M., and Markel, H. 2000. Making history: Thomas Francis, Jr., M.D. The 1954 Salk
poliomyelitis vaccine field trip. Arch. Pediatr. Adolesc. Med., 154:512-517.
E. J. Calabrese
94
4
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 1, Art. 10
https://scholarworks.umass.edu/dose_response/vol10/iss1/10
Morgan, J.F., Morton, H.J., and Parker, R.C. 1950. Nutrition of animal cells in tissue culture. I. Initial
studies on a synthetic medium. Proc. Soc. Exp. Biol. Med., 73:1-8.
Morton, H.J., Morgan, J.F., and Parker, R.C. 1950. Nutrition of animal cells in tissue cultures. II. Use
of Tweens in synthetic medium. Proc. Soc. Exp. Biol. Med., 74:22-26.
Parker, R.C., Morgan, J.F., and Morton, H.J. 1950. Nutrition of animal cells in tissue culture. III.
Effect of ethyl alcohol on cell survival and multiplication. J. Cell. Comp. Physiol. 36(3):411-420.
Rhodes, A.J. 1956. Research on the development of a poliomyelitis vaccine: Toronto, 1950-1953.
Canad. M. A. J., 75:48-49.
Salk, J.E. 1953. Studies in human subject on active immunization against poliomyelitis. I. A prelimi-
nary report of experiments in progress. JAMA, 151:1081-1098.
Schulz, H. 1887. Zur Lehre von der Arzneiwirdung. Virchows Arch. Pathol. Anat. Physiol. Klin. Med.,
108:423-445.
Schulz, H. 1888. Uber Hefegifte. Pflugers Archiv. Fur die gesamte Physiologie des Menschen und der Tiere,
42:517-541.
Southam, C.M., and Ehrlich, J. 1943. Effects of extract of western red-cedar heartwood on certain
wood-decaying fungi in culture. Phytopathology, 33:517-524.
Hormesis and the Salk Polio Vaccine
95
5
Calabrese: HORMESIS AND THE SALK POLIO VACCINE
Published by ScholarWorks@UMass Amherst, 2014
